HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

K Oshimi Selected Research

Neoplasms (Cancer)

5/2008Hsp90-inhibitor geldanamycin abrogates G2 arrest in p53-negative leukemia cell lines through the depletion of Chk1.
2/2006Hematopoietic stem cell transplantation for natural killer-cell lineage neoplasms.
10/2001Molecular analysis of tumor suppressor genes, Rb, p53, p16INK4A, p15INK4B and p14ARF in natural killer cell neoplasms.
8/2000A metalloproteinase inhibitor prevents acute graft-versus-host disease while preserving the graft-versus-leukaemia effect of allogeneic bone marrow transplantation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


K Oshimi Research Topics

Disease

4Neoplasms (Cancer)
05/2008 - 08/2000
3Leukemia
05/2008 - 08/2000
2Lymphoma (Lymphomas)
08/2010 - 07/2000
1Starvation
08/2010
1Blast Crisis (Blast Phase)
06/2009
1Bacterial Meningitis
06/2009
1Necrosis
05/2008
1T-Cell Leukemia (Leukemia, T Cell)
06/2006
1Aneuploidy (Aneuploid)
06/2006
1Acute Erythroblastic Leukemia (Erythroleukemia)
08/2005
1Acute Megakaryoblastic Leukemia (Leukemia, Megakaryocytic)
08/2005
1Large Granular Lymphocytic Leukemia
03/2004
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
10/2001
1Myelodysplastic Syndromes (Myelodysplastic Syndrome)
08/2001
1Prostatic Neoplasms (Prostate Cancer)
08/2001
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
07/2001
1Ataxia Telangiectasia (Louis Bar Syndrome)
09/2000
1Graft vs Host Disease (Graft-Versus-Host Disease)
08/2000
1Hypergammaglobulinemia (Hyperimmunoglobulinemia)
04/2000
1Pleural Effusion (Pleural Effusions)
04/2000
1Brain Neoplasms (Brain Tumor)
02/2000
1Septic Shock (Toxic Shock Syndrome)
02/2000
1Hematologic Diseases (Blood Diseases)
02/2000
1Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome)
02/2000
1Infections
02/2000
1Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated)
01/2000
1Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria)
01/2000
1Dyspnea (Shortness of Breath)
01/2000
1Renal Insufficiency (Renal Failure)
01/2000

Drug/Important Bio-Agent (IBA)

3DNA (Deoxyribonucleic Acid)IBA
05/2008 - 07/2000
2Doxorubicin (Adriamycin)FDA LinkGeneric
05/2008 - 09/2000
2Proteins (Proteins, Gene)FDA Link
06/2006 - 10/2001
2Antiphospholipid AntibodiesIBA
07/2001 - 02/2000
1alpha- cyano- (3,4- dihydroxy)- N- benzylcinnamideIBA
08/2010
1Antineoplastic Agents (Antineoplastics)IBA
08/2010
1geldanamycinIBA
05/2008
1NocodazoleIBA
06/2006
1Messenger RNA (mRNA)IBA
08/2005
1Tumor Suppressor Protein p14ARF (p14ARF)IBA
10/2001
1LigandsIBA
10/2001
1E-SelectinIBA
10/2001
1EstramustineFDA Link
08/2001
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
08/2000
1Fas Ligand Protein (Fas Ligand)IBA
08/2000
1Metalloproteases (Metalloproteinases)IBA
08/2000
1KB R7785IBA
08/2000
1C-Reactive ProteinIBA
04/2000
1Interleukin-6 (Interleukin 6)IBA
04/2000
1Amikacin (A.M.K)FDA LinkGeneric
02/2000
1Daunorubicin (Cerubidine)FDA LinkGeneric
02/2000
1Adrenal Cortex Hormones (Corticosteroids)IBA
02/2000
1CefozopranIBA
02/2000
1Cytarabine (Cytosar-U)FDA LinkGeneric
02/2000
1HLA-DR Antigens (HLA-DR)IBA
01/2000
1HaptoglobinsIBA
01/2000
1Protease Inhibitors (Protease Inhibitor)IBA
01/2000

Therapy/Procedure

3Therapeutics
06/2009 - 01/2000
1Drug Therapy (Chemotherapy)
08/2010
1Hematopoietic Stem Cell Transplantation
02/2006
1Aftercare (After-Treatment)
08/2001
1Bone Marrow Transplantation (Transplantation, Bone Marrow)
08/2000